AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
AZD2171 是一种泛 VEGF 受体酪氨酸激酶抑制剂，可使胶质母细胞瘤患者的肿瘤血管正常化并减轻水肿
期刊:Cancer Cell
影响因子:48.8
doi:10.1016/j.ccr.2006.11.021
Tracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, Wei-Ting Zhang, Dan G Duda, Kenneth S Cohen, Kevin R Kozak, Daniel P Cahill, Poe-Jou Chen, Mingwang Zhu, Marek Ancukiewicz, Maciej M Mrugala, Scott Plotkin, Jan Drappatz, David N Louis, Percy Ivy, David T Scadden, Thomas Benner, Jay S Loef
